Abstract:Objective: To detect the expression of miR-221/222 in serum and plasma cells in patients with monoclonal gammopathy of undetermined significance(MGUS) and multiple myeloma(MM), and to explore the possibility of miR-221/222 as biomarkers in the diagnosis and prognosis predicting of MGUS and MM. Methods: Bone marrow and serum samples from 14 patients with newly diagnosed MGUS, 81 patients with newly diagnosed or relapsed MM and 10 controls were collected from Sir Run Run Shaw Hospital of Zhejiang University and Tongde Hospital of Zhejiang Province during January 2013 and December 2015. The expressions of miR-221/222 in serum and in sorted CD138 positive plasma cells were detected by qRT-PCR, and the relative expression of miR-221/222 (Δct) was compared between the groups. Serum levels of miR-221 before and after treatment were compared in both remission group (n=22) and refractory group (n=13) in MM patients, and its correlation with serum level of β2-MG was assessed using Pearson's correlation analysis. Results: Serum levels of miR-221/222 in MGUS and MM groups were significantly higher than those in control group (all P<0.01), while miR-221/222 levels in plasma cells were significantly lower in MGUS and MM groups than those in the control group (P<0.05 or<0.01). No significant difference in miR-221/222 levels in serum and plasma cells was observed between MGUS group and MM group (all P>0.05). There was no correlation between miR-221/222 levels in serum and plasma cells (r=0.024 and -0.127, all P>0.05), but miR-221 levels were correlated with miR-222 levels in both serum and plasma cells (r=0.534 and 0.552, all P<0.01). Receiver operating characteristic (ROC) curves showed that the areas under the curve (AUCs) of serum miR-221/222, plasma cell miR-221/222 in diagnosis of MGUS/MM were 0.968, 0.976, 0.801 and 0.727, respectively. There was no significant difference in serum level of miR-221 among MM patients with different paraprotein isotypes (P>0.05), but serum level of miR-221 in patients with relapsed MM was higher than that in patients with newly diagnosed MM (P<0.01). Compared with the patients with MGUS or MM stageⅠ and Ⅱ, patients with MM stage Ⅲ were of higher serum levels of miR-221 (P<0.01). Serum level of miR-221 decreased after chemotherapy in the remission group (U=51.5, P<0.01), but such decrease was not observed in the refractory group (U=67.5, P>0.05). Serum level of β2-MG was positively correlated with serum level of miR-221 (r=0.524, P<0.01). Conclusion: miR-221/222 in serum and plasma cells may be biomarkers for early diagnosis of MGUS, and are helpful for diagnosis and efficacy evaluation of MM.

Host Serum Mir-223 is a Potential New Biomarker for Schistosoma Japonicum Infection and the Response to Chemotherapy

Altered levels of circulating miRNAs are associated Schistosoma japonicum infection in mice.

[Expression of Microrna-221/222 in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma].

MicroRNA Expression Profile in Different Tissues of BALB/c Mice in the Early Phase of Schistosoma Japonicum Infection

ALTERED EXPRESSIONS OF MIR-17-92 CLUSTER IN MOUSE LIVER ASSOCIATED WITH SCHISTOSOMA JAPONICUM INFECTION

Identification of deregulated microRNAs in hepatic stellate cells from mice infected with Schistosoma japonicum

Deep Sequencing-Based Identification of Pathogen-Specific Micrornas in the Plasma of Rabbits Infected Withschistosoma Japonicum

[Changes of Liver Fibrosis-Related Mirnas Induced by Soluble Egg Antigen of Schistosoma Japonicum].

A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III

Induction of hepatic fibrosis in mice with schistosomiasis by extracellular microRNA-30 derived from Schistosoma japonicum eggs

Schistosomal MicroRNAs Isolated From Extracellular Vesicles in Sera of Infected Patients: A New Tool for Diagnosis and Follow-up of Human Schistosomiasis

Investigation on the role of praziquantel against Schistosoma japonicum induced liver fibrosis and expression change of host miRNA

A Novel miRNA From Egg-Derived Exosomes of Schistosoma japonicum Promotes Liver Fibrosis in Murine Schistosomiasis

Characterization of MicroRNA Cargo of Extracellular Vesicles Isolated from the Plasma of Schistosoma Japonicum-Infected Mice

Expression profiles of circulatingmicroRNAs in newly-developed advanced schistosomiasis patients

Cross-Species Suppression of Hepatoma Cell Growth and Migration by a Schistosoma Japonicum MicroRNA

Comparative Characterization of Micrornas of Schistosoma Japonicum from SCID Mice and BALB/c Mice: Clues to the Regulation of Parasite Growth and Development

A MicroRNA Derived from Schistosoma Japonicum Promotes Schistosomiasis Hepatic Fibrosis by Targeting Host Secreted Frizzled-Related Protein 1

MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7

Dynamic miRNA profile of host T cells during early hepatic stages of Schistosoma japonicum infection

Proteomics Investigations of Potential Protein Biomarkers in Sera of Rabbits Infected With Schistosoma japonicum